David P. Sparling, MD,PhD
Pediatric Endocrinologist
(16 Ratings)
, 5 Comments
VIEW ALL COMMENTS
About David Sparling
Dr. Sparling graduated summa cum laude from the University of Oklahoma in 2001 and went on to pursue his MD/PhD at the University of Oklahoma Health Sciences Center, completing his degrees in 2009. He completed his pediatrics residency and a fellowship in pediatric endocrinology at the New York-Presbyterian Morgan Stanley Children’s Hospital through the Columbia University College of Physicians and Surgeons. He returned to OU and is now an Assistant Professor in the section of Pediatric Diabetes and Endocrinology at the OU College of Medicine, and is a member of the Harold Hamm Diabetes Center. He has a special clinical interest in type 1 diabetes mellitus, and his research focuses both on diagnosis and management of children with type 1 diabetes as the site primary investigator for TrialNet and the Type 1 Diabetes Exchange. He also now has his own NIH-sponsored K mentored training award examining the role of adipocytes in inflammation.
Affiliations
Oklahoma Children's Hospital,
OU Health Physicians - Children's Diabetes & Endocrinology,
OU Health Harold Hamm Diabetes Center,
Oklahoma Children’s Hospital – Norman Specialty Clinic
Awards
OU Medicine Award for Outstanding Patient Service, OU Medicine
2018
OU Medicine Award for Outstanding Patient Service, OU Medicine
2017
Health Education
College
B.S, summa cum laude, Chemistry-Biochemistry option
University of Oklahoma Norman, OK 2001
Medical School
Medical Degree
University of Oklahoma College of Medicine Oklahoma City, OK 2009
Residency
Pediatric Residency
NewYork-Presbyterian Morgan Stanley Children’s Hospital, Columbia Unversity Medical Center New York City, NY 2011
Fellowship
Pediatric Endocrinology
Columbia Unversity Medical Center New York City, NY 2015
Board Certification
American Board of Pediatrics
2012
American Board of Pediatrics, Subboard of Pediatric Endocrinology
2015
Medical Interests
Areas of Interest:
Diagnosis and Treatment of Diseases Affecting the Endocrine System, including the care of children with Type 1 diabetes, as well as disorders involving the thyroid, growth, and puberty